Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiac Surgery
ATS Medical Announces $20 Million in Proceeds From a Private Equity Financing and Announces Resolution of Litigation
January 11th, 2009
ATS Medical, Inc. (NASDAQ:ATSI), a manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced that it has closed a $20 million equity financing with Essex Woodlands Health Ventures. In connection with the financing, ATS Medical issued and sold to Essex Woodlands 8,510,639 shares of its common stock at a purchase price of $2.35 per share, and warrants to purchase 2,533,192 shares of common stock at an exercise price of $2.475 per share during the first year after the closing, $2.85 per share during the second year, and $3.10 thereafter. "With ATS Medical's technological innovation, strong product portfolio and experienced management...
Source: Pharma Investments, Ventures & Law Weekly (2009-01-11)
|
